GGrantIndex
← Leaderboards

Michael A. Farrar

University Of Minnesota

$20,040,780
Attributed
$21,570,688
Total exposure
13
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,570,688 · 13

By mechanism

R01$20,528,432 · 10
R56$753,849 · 2
R21$288,407 · 1

Top collaborators

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Play

Research focus

PlayCellsPreventGrantRegulatory T-LymphocyteTranscription FactorProgenitorSignal TransductionGenesT-LymphocyteComplexMolecularFoxp3 GeneMouse ModelImmune ResponseDefectPathway InteractionsAffectLeadBaseThymus GlandImmuneT-Cell DevelopmentAntigens

Grant awards (56)

Regulatory T Cells in Alzheimer's Disease$753,422
R01 · FY2025 · AG · contact PI
Development of Immune Tolerance$427,251
R01 · FY2025 · AI · contact PI
Regulation of central tolerance and Treg development by recirculating Treg$387,500
R01 · FY2025 · AI · contact PI
Regulatory T Cells in Alzheimer's Disease$768,798
R01 · FY2024 · AG · contact PI
Development of Immune Tolerance$447,130
R01 · FY2024 · AI · contact PI
Regulation of central tolerance and Treg development by recirculating Treg$387,500
R01 · FY2024 · AI · contact PI
Regulatory T Cells in Alzheimer's Disease$768,798
R01 · FY2023 · AG · contact PI
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function$484,777
R01 · FY2023 · AI · contact PI
Development of Immune Tolerance$453,657
R01 · FY2023 · AI · contact PI
Regulation of central tolerance and Treg development by recirculating Treg$387,500
R01 · FY2023 · AI · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$369,126
R01 · FY2023 · CA · contact PI
Regulatory T Cells in Alzheimer's Disease$768,798
R01 · FY2022 · AG · contact PI
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function$484,777
R01 · FY2022 · AI · contact PI
Development of Immune Tolerance$460,057
R01 · FY2022 · AI · contact PI
Regulation of central tolerance and Treg development by recirculating Treg$387,500
R01 · FY2022 · AI · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$369,126
R01 · FY2022 · CA · contact PI
Regulatory T Cells in Alzheimer's Disease$364,654
R01 · FY2022 · AI · contact PI
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function$484,777
R01 · FY2021 · AI · contact PI
Development of Immune Tolerance$460,605
R01 · FY2021 · AI · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$376,660
R01 · FY2021 · CA · contact PI
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function$484,777
R01 · FY2020 · AI · contact PI
Development of Immune tolerance$385,000
R01 · FY2020 · AI · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$383,007
R01 · FY2020 · CA · contact PI
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function$484,777
R01 · FY2019 · AI · contact PI
Development of Immune tolerance$385,000
R01 · FY2019 · AI · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$383,812
R01 · FY2019 · CA · contact PI
Development of Immune tolerance$384,234
R01 · FY2018 · AI · contact PI
Development of Immune tolerance$381,933
R01 · FY2017 · AI · contact PI
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia$312,304
R01 · FY2017 · CA · contact PI
Development of Immune tolerance$393,200
R01 · FY2016 · AI · contact PI
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia$312,341
R01 · FY2016 · CA · contact PI
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia$312,377
R01 · FY2015 · CA · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$310,387
R01 · FY2015 · CA · contact PI
Transponson-based screens for genes involved in acute lymphoblastic Leukemia$289,464
R01 · FY2015 · CA · contact PI
TNF Receptor Superfamily Signaling in Immune Tolerance$376,431
R56 · FY2014 · AI · contact PI
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia$310,254
R01 · FY2014 · CA · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$301,130
R01 · FY2014 · CA · contact PI
Transponson-based screens for genes involved in acute lymphoblastic Leukemia$286,395
R01 · FY2014 · CA · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$291,868
R01 · FY2013 · CA · contact PI
Transponson-based screens for genes involved in acute lymphoblastic Leukemia$283,089
R01 · FY2013 · CA · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$310,551
R01 · FY2012 · CA · contact PI
Transponson-based screens for genes involved in acute lymphoblastic Leukemia$307,181
R01 · FY2012 · CA · contact PI
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia$310,044
R01 · FY2011 · CA · contact PI
Transponson-based screens for genes involved in acute lymphoblastic Leukemia$308,891
R01 · FY2011 · CA · contact PI
Regulation of Suppressor T Cell Development by STAT5$377,418
R56 · FY2010 · AI · contact PI
Regulation of Suppressor T Cell Development by STAT5$351,869
R01 · FY2008 · AI · contact PI
Regulation of Suppressor T Cell Development by STAT5$358,800
R01 · FY2007 · AI · contact PI
Regulation of B Cell Development by Ras and Raf$276,500
R01 · FY2007 · AI · contact PI
Regulation of Suppressor T Cell Development by STAT5$314,201
R01 · FY2006 · AI · contact PI
Regulation of B Cell Development by Ras and Raf$284,816
R01 · FY2006 · AI · contact PI
Regulation of Suppressor T Cell Development by STAT5$40,592
R01 · FY2006 · AI · contact PI
Regulation of Suppressor T Cell Development by STAT5$321,875
R01 · FY2005 · AI
Regulation of B Cell Development by Ras and Raf$291,728
R01 · FY2005 · AI
Regulation of B Cell Development by Ras and Raf$291,784
R01 · FY2004 · AI
Regulation of B Cell Development by Ras and Raf$291,838
R01 · FY2003 · AI
Regulation of B Cell Development by Ras and Raf$288,407
R21 · FY2002 · AI